All In Biotech

Drug Trial Radar · NCT05076838

Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy

An Open-Label, Single-Dose, Pharmacokinetics Study of VALTOCO® With Open-Label Safety Period in Pediatric Subjects With Epilepsy

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

36

Actual

Start

Nov 8, 2021

Primary completion

Mar 11, 2025

Study completion Mar 11, 2025

Sponsor

Lead sponsor
Neurelis, Inc.Industry
Sponsor type
Industry
First posted
Oct 13, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 5 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 1/2a, open-label, single-dose, PK study of VALTOCO with open-label safety period in pediatric epilepsy subjects age 2 to 5 years.

Conditions

  • Epilepsy

Interventions

  • Diazepam Nasal Spray [Valtoco]Drug

    5 mg, 10 mg, or 15 mg dose of intranasal VALTOCO will be administered based on the subject's body weight.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Plasma Concentration (Cmax) of Diazepam After Intranasal VALTOCO Administered to Subjects With Epilepsy 2 to 5 Years of AgeTime frame: 0-6 hours

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Northwest Florida Clinical Research Group, LLC.

    Gulf Breeze, Florida

  • Nicklaus Children's Hospital

    Miami, Florida

  • AdventHealth Research Institute

    Orlando, Florida

  • Center for Rare Neurological Diseases

    Norcross, Georgia

  • Massachusetts General Hospital

    Boston, Massachusetts

  • University of Missouri Women & Children's Hospital

    Columbia, Missouri

  • Northeast Regional Epilepsy Group

    Hackensack, New Jersey

  • Boston Children's Health Physicians

    Hawthorne, New York

  • University of Rochester

    Rochester, New York

  • Duke University Hospital

    Durham, North Carolina

  • Le Bonheur Children's Hospital

    Memphis, Tennessee

  • UT Southwestern Medical Center

    Dallas, Texas

  • Children's Hospital of the King's Daughters

    Norfolk, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.